MediciNova (MNOV) Posts MN-001 Phase 2 Topline in NAFLD/T2DM
MediciNova reported Phase 2 topline data for MN-001 showing a statistically significant TG reduction at Week 4, significant increases in HDL-C and HDL-P, and numerical trends in liver fat and body weight; safety was generally favorable.Material DetailsContext by AI AnalystThis is an exploratory, 40…